Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 374

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 374
---
 political factors; |

| • |     | the difficulties and management challenges inherent in completing the Mergers and integrating the business, operations and workforce of Kineta and TuHURA and the risk of not capturing all the anticipated synergies and the risk that other anticipated benefits of the Mergers might not be realized; |

| • |     | the amount of time it could take to complete the Mergers, including that completion of the Mergers depends on factors outside of Kineta’s or TuHURA’s control, and the risk that the pendency of the Mergers for an extended period of time following the announcement of the execution of the Merger Agreement could have an adverse impact on Kineta or TuHURA, including their respective customer, supplier and other business relationships; |

| • |     | the possible diversion of management attention for an extended period of time during the pendency of the Mergers; |

| • |     | the risk that, despite the retention efforts of Kineta and TuHURA prior to the consummation of the Mergers, Kineta and TuHURA may lose key personnel; |

| • |     | the provisions of the Merger Agreement that prohibit Kineta from soliciting other acquisition proposals and the potential payment to TuHURA by Kineta of a termination fee of $1,000,000, as described in the section entitled “The Merger Agreement—Termination Fees”; |

| • |     | that certain provisions of the Merger Agreement, including the $1,000,000 termination fee, may have the effect of discouraging alternative proposals to acquire Kineta; |

| • |     | the risk that if TuHURA fails to complete the Mergers as a result of a breach of the Merger Agreement in certain circumstances, remedies may be limited to the termination fee of $1,000,000, as described in the section entitled “The Merger Agreement—Termination Fees”, which may be inadequate to compensate Kineta for the damage caused, and if available, other rights and remedies may be expensive and difficult to enforce, and the success of any such action may be uncertain; |

| • |     | the potential for litigation relating to the Mergers and the associated costs, burden and inconvenience involved in defending those proceedings; |

| • |     | the restrictions in the Merger Agreement on the conduct of Kineta’s business during the period between execution of the Merger Agreement and the consummation of the Mergers